(19)

(11)

EP 4 568 683 A2

(12)

(88) Date of publication A3: 25.04.2024 (43) Date of publication: 18.06.2025 Bulletin 2025/25 (21) Application number: 23853406.9 (22) Date of filing: 11.08.2023

(51) International Patent Classification (IPC):  A61K 31/713(2006.01) A61K 39/395(2006.01) A61K 35/17(2025.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): C07K 16/3069; C07K 2317/92 (86) International application number: PCT/US2023/030115 (87) International publication number: WO 2024/035953 (15.02.2024 Gazette 2024/07)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 11.08.2022 US 202263397296 P (71) Applicant: Adicet Therapeutics, Inc. Redwood City, CA 94065 (US)

(72) Inventors: AFTAB, Blake Redwood City, CA 94065 (US) BHAT, Arun Redwood City, CA 94065 (US) RAMADOSS, Nitya Redwood City, CA 94065 (US) NISHIMOTO, Kevin Redwood City, CA 94065 (US) AZAMEERA, Aruna Redwood City, CA 94065 (US) MEADDOUGH, Erika Redwood City, CA 94065 (US) SPELTZ, Betsy Redwood City, CA 94065 (US) TEAGUE, Alex Redwood City, CA 94065 (US) DING, Beibei Redwood City, CA 94065 (US) (74) Representative: Mathys & Squire  The Shard 32 London Bridge Street London SE1 9SG London SE1 9SG (GB)